Vamil Divan
Stock Analyst at Guggenheim
(3)
# 460
Out of 5,269 analysts
264
Total ratings
58.25%
Success rate
36.85%
Average return
Main Sectors:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
Vera Therapeutics | Maintains: Strong Buy | 59 61 | 28.98 | 110.49% | 5 | Feb 27, 2025 | |
Insmed | Reiterates: Buy | 101 101 | 78.5 | 28.66% | 6 | Feb 25, 2025 | |
Merck & Co | Maintains: Buy | 122 115 | 92.29 | 24.61% | 8 | Feb 12, 2025 | |
Pfizer | Reiterates: Buy | 33 33 | 26.44 | 24.81% | 15 | Feb 10, 2025 | |
AbbVie | Maintains: Strong Buy | 212 214 | 210.27 | 1.77% | 20 | Feb 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 162 166 | 166.39 | -0.23% | 12 | Feb 3, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | n/a | n/a | n/a | 5 | Jan 17, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 7 4 | n/a | n/a | 6 | Dec 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 10 10 | 3.62 | 176.24% | 2 | Dec 3, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 23 41 | 20.86 | 96.55% | 7 | Oct 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 6 | 1.21 | 395.87% | 1 | Sep 10, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 2 | Jun 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 77 77 | 59.92 | 28.5% | 8 | Apr 23, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 55 | n/a | n/a | 1 | Apr 9, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 245 330 | n/a | n/a | 7 | Jan 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 19 20 | 7.28 | 174.73% | 9 | Sep 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 21 18 | n/a | n/a | 2 | Aug 18, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 26 | 0.26 | 9900% | 2 | Jun 15, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 35 40 | n/a | n/a | 3 | Jun 12, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 8 9 | 1.02 | 782.35% | 2 | Apr 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | n/a | n/a | n/a | 1 | Mar 1, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 13 2 | n/a | n/a | 5 | Nov 15, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 27 19 | 18.66 | 1.82% | 7 | Aug 10, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 95 98 | 116.71 | -16.03% | 8 | Aug 8, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 36 34 | 34.6 | -1.73% | 7 | Jul 28, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 20 10 | 1.74 | 474.71% | 3 | May 25, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 51 49 | 127.51 | -61.57% | 3 | May 3, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 315 356 | 922.78 | -61.42% | 15 | May 2, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 8 6 | 3.76 | 59.57% | 1 | Mar 16, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 144 154 | 34.35 | 348.33% | 9 | Mar 3, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 15 | 14.47 | 3.66% | 5 | May 6, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 6 | Dec 13, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 7 4 | n/a | n/a | 6 | Nov 8, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 11 19 | n/a | n/a | 8 | Sep 17, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Neutral | 35 | n/a | n/a | 13 | Aug 5, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Neutral | n/a | n/a | n/a | 13 | Jul 10, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Outperform | 36 30 | n/a | n/a | 4 | May 21, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 161 155 | n/a | n/a | 10 | Mar 7, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Outperform | 15 | 4.12 | 264.08% | 4 | Aug 15, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 58 61 | 59.58 | 2.38% | 5 | Jul 27, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 103 | 1.7 | 5958.82% | 3 | Jan 17, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 45 55 | n/a | n/a | 1 | Sep 19, 2017 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 66 120 | n/a | n/a | 4 | Dec 20, 2016 |